Agenus Inc news

   Watch this stock
Showing stories 1 - 10 of about 44   

Articles published

AGEN 3.11 +0.02 (0.65%)
price chart
Agenus Inc - A Potential New Play On Ebola
Shares of Agenus Inc (NASDAQ: AGEN) have moved to the upside in Monday's trade as the company is being mentioned as a potential play on Ebola.
Related articles »  
Watch List : SunPower Corporation (NASDAQ:SPWR), Transocean (NYSE:RIG ...
Agenus Inc. (NASDAQ:AGEN) will report its third quarter 2014 financial results before the market opens on Friday October 31 2014.
Rising Stocks: Agenus Inc(NASDAQ:AGEN), RadioShack Corporation(NYSE ...
Agenus Inc(NASDAQ:AGEN) currently has a market capitalization of $184.9 million and 62.68 million tradeable shares. The stock currently has a bid price of $3.00 x 200 and an offer price of $3.18 x 600.
Related articles »  
Agenus posts 3Q loss
NEW YORK (AP) _ Agenus Inc. (AGEN) on Friday reported a loss of $8.1 million, or 13 cents per share, in its third quarter. The company, based in New York, posted revenue of $1.6 million in the period.
Related articles »  
Agenus Reports Third Quarter 2014 Financial Results
LEXINGTON, Mass., Oct 31, 2014 (BUSINESS WIRE) -- Agenus Inc. AGEN, +2.32% an immuno-oncology company with a development pipeline of checkpoint modulators (CPMs), heat shock protein peptide-based vaccines, and adjuvants, today announced ...
Agenus (AGEN) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS  WKRB News
Related articles »  
Will Agenus (AGEN) Incur Wider-than-Expected Q3 Loss?
Agenus posted positive surprises in three of the last four quarters with an average beat of 35.47%. However, things are not looking good since the second quarter.
Related articles »  
Agenus to Report Third Quarter 2014 Financial Results on October 31, 2014 ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (NASDAQ: AGEN) will report its third quarter 2014 financial results before the market opens on Friday, October 31, 2014.
Fast Moving Stocks: American Airlines Group Inc. (NASDAQ:AAL), Vical ...
Biotech companies and the town of Lexington split the cost for shuttle buses that carry workers from Alewife Station to biotech research parks.
Some biotechs decamp for Lexington, seeking room to grow
Garo Armen, chief executive of Agenus Inc., said the town offers better amenities, such as more restaurants and a nicer hotel nearby, than it did in 2004, when his company signed a 30-year lease there.
Global Therapeutics Market shows a tremendous growth
Companies profiled in the report are Dendreon Corp, Agenus Inc., Bavarian Nordic A/S, Novartis International AG, GlaxoSmithKline plc, Argos Therapeutics Inc., AFFiRiS AG, CEL-SCI Corp, Celldex Therapeutics Inc., GlobeImmune Inc., Cytos Biotechnology ...